ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,896.86
0.17%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aevi Genomic Medicine Inc (GNMX)

  7. Aevi Genomic Medicine Inc (GNMX) News

Aevi Genomic Medicine (GNMX)

Aevi Genomic Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GNMX
DateTimeSourceHeadlineSymbolCompany
14/02/202021:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
14/02/202015:57Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:GNMXAevi Genomic Medicine Inc
14/02/202011:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
14/02/202011:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
14/02/202011:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202021:30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202020:49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202020:49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202020:48Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202020:47Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202020:45Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202020:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202020:43Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202020:42Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202020:42Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202020:41Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202020:40Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202017:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202017:58Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202017:57Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GNMXAevi Genomic Medicine Inc
05/02/202021:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/02/202021:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/02/202021:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/02/202021:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/02/202021:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/02/202021:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/02/202021:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/02/202021:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/02/202021:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/02/202021:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:GNMX

Your Recent History

LSE
PET
Petrel Resources
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
SCE
Surface Transforms
LSE
SCLP
Scancell
LSE
GKP
Gulf Keystone Petroleum
LSE
POS
Plexus
LSE
AGL
Angle
LSE
EEE
Empire Metals
LSE
BT.A
Bt
LSE
PANR
Pantheon Resources
LSE
OXB
Oxford Biomedica
LSE
ITV
Itv
LSE
SRSP
Sirius Petroleum
LSE
GOLD
LSE
ENET
Ethernity Networks
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved